EE04737B1 - Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega - Google Patents
Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainegaInfo
- Publication number
- EE04737B1 EE04737B1 EEP199900574A EEP9900574A EE04737B1 EE 04737 B1 EE04737 B1 EE 04737B1 EE P199900574 A EEP199900574 A EE P199900574A EE P9900574 A EEP9900574 A EE P9900574A EE 04737 B1 EE04737 B1 EE 04737B1
- Authority
- EE
- Estonia
- Prior art keywords
- prevention
- compositions
- factor
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9707368A FR2764511B1 (fr) | 1997-06-13 | 1997-06-13 | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
PCT/FR1998/001172 WO1998056365A1 (fr) | 1997-06-13 | 1998-06-09 | INHIBITEUR DU FACTEUR Xa SEUL OU EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE, CONTRE LA THROMBOSE ARTERIELLE |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9900574A EE9900574A (et) | 2000-08-15 |
EE04737B1 true EE04737B1 (et) | 2006-12-15 |
Family
ID=9507960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP199900574A EE04737B1 (et) | 1997-06-13 | 1998-06-09 | Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega |
Country Status (43)
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
EP1156803A4 (en) | 1999-02-09 | 2004-03-17 | Bristol Myers Squibb Co | FXA LACTAM INHIBITORS AND METHOD |
US6344450B1 (en) | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
FR2793687B1 (fr) * | 1999-04-26 | 2001-08-24 | Sanofi Sa | Nouvelle composition injectable d'un anticoagulant |
FR2800074B1 (fr) * | 1999-10-22 | 2001-12-21 | Aventis Pharma Sa | Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant |
US6544981B2 (en) | 2000-06-09 | 2003-04-08 | Bristol-Myers Squibb Company | Lactam inhibitors of factor Xa and method |
US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
DE60217835D1 (en) | 2001-02-28 | 2007-03-15 | John H Griffin | Plasmaglucosylceramiddefizienz als risikofaktor für thrombose und modulator von anticoagulant protein c |
UA80399C2 (en) * | 2001-11-13 | 2007-09-25 | Glaxo Group Ltd | Use of specific dose of fondaparinux sodium for the treatment of acs |
WO2004031143A2 (en) | 2002-10-02 | 2004-04-15 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
WO2004048363A1 (ja) * | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | イミダゾール誘導体、その製造法および用途 |
EP1679067A4 (en) * | 2003-09-19 | 2010-04-07 | Kissei Pharmaceutical | COMBINED MEDICINES |
WO2005087266A1 (en) * | 2004-03-05 | 2005-09-22 | Vddi Pharmaceuticals | Combination therapy for inhibition of platelet aggregation |
CN1914915A (zh) * | 2004-04-23 | 2007-02-14 | 住友电气工业株式会社 | 活动图像数据的编码方法、解码方法及实施这些方法的终端装置、以及双向对话型系统 |
TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
US7563780B1 (en) * | 2004-06-18 | 2009-07-21 | Advanced Cardiovascular Systems, Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
JP5557410B2 (ja) * | 2004-07-13 | 2014-07-23 | 第一三共株式会社 | 経口投与による血栓・塞栓の予防治療剤 |
US20070105825A1 (en) * | 2004-09-16 | 2007-05-10 | Yuji Hoyano | Concurrent drugs |
AU2006301240A1 (en) * | 2005-10-10 | 2007-04-19 | Msd Oss B.V. | Antithrombotic compound |
CA2735983A1 (en) * | 2008-09-10 | 2010-03-18 | Transpharma Medical Ltd. | Transdermal delivery of oligosaccharides |
WO2011149110A1 (en) | 2010-05-28 | 2011-12-01 | Daiichi Sankyo Company, Limited | Novel composition for the prevention and/or treatment of thromboembolism |
CA2966249C (en) * | 2014-10-30 | 2019-06-18 | Chengdu Baiyu Pharmaceutical Co., Ltd. | Pharmaceutical composition containing ginkgolide b and xa factor inhibitor, preparation method thereof and use thereof |
CN106860868B (zh) * | 2015-12-11 | 2019-11-22 | 北京百奥药业有限责任公司 | 沙班类药物与蚓激酶的药物组合物、制剂及其应用 |
US11654036B2 (en) | 2020-05-26 | 2023-05-23 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2548189B1 (fr) * | 1983-07-01 | 1986-04-11 | Choay Sa | Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques |
ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
FR2728901B1 (fr) * | 1994-12-28 | 1997-03-28 | Sanofi Sa | Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
DK0946185T4 (da) | 1996-11-27 | 2010-08-30 | Aventis Pharma Inc | Farmaceutisk præparat, som omfatter en forbindelse med anti-Xa-aktivitet og en blodpladeaggregations antagonistforbindelse |
FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
-
1997
- 1997-06-13 FR FR9707368A patent/FR2764511B1/fr not_active Expired - Lifetime
-
1998
- 1998-06-09 KR KR1019997011705A patent/KR100598451B1/ko not_active IP Right Cessation
- 1998-06-09 EE EEP199900574A patent/EE04737B1/et unknown
- 1998-06-09 ID IDW991574A patent/ID29309A/id unknown
- 1998-06-09 WO PCT/FR1998/001172 patent/WO1998056365A1/fr active IP Right Grant
- 1998-06-09 DK DK98929521T patent/DK0986376T3/da active
- 1998-06-09 RS YUP-636/99A patent/RS49902B/sr unknown
- 1998-06-09 NZ NZ501452A patent/NZ501452A/en not_active IP Right Cessation
- 1998-06-09 EP EP98929521A patent/EP0986376B1/fr not_active Expired - Lifetime
- 1998-06-09 UA UA99126569A patent/UA70919C2/uk unknown
- 1998-06-09 TR TR1999/03087T patent/TR199903087T2/xx unknown
- 1998-06-09 JP JP50176599A patent/JP3988803B2/ja not_active Expired - Lifetime
- 1998-06-09 US US09/445,555 patent/US6541488B1/en not_active Expired - Lifetime
- 1998-06-09 HU HU0002175A patent/HU227956B1/hu unknown
- 1998-06-09 SK SK1709-99A patent/SK286311B6/sk not_active IP Right Cessation
- 1998-06-09 IL IL13345298A patent/IL133452A/en not_active IP Right Cessation
- 1998-06-09 ME MEP-1999-636A patent/ME00685B/me unknown
- 1998-06-09 AU AU79246/98A patent/AU728826B2/en not_active Expired
- 1998-06-09 SI SI9830906T patent/SI0986376T1/sl unknown
- 1998-06-09 DE DE69839046T patent/DE69839046T2/de not_active Expired - Lifetime
- 1998-06-09 ES ES98929521T patent/ES2299209T3/es not_active Expired - Lifetime
- 1998-06-09 CZ CZ0446099A patent/CZ299518B6/cs not_active IP Right Cessation
- 1998-06-09 PL PL98337288A patent/PL193405B1/pl unknown
- 1998-06-09 RU RU2000100812/14A patent/RU2212886C2/ru active
- 1998-06-09 PT PT98929521T patent/PT986376E/pt unknown
- 1998-06-09 CA CA2293415A patent/CA2293415C/en not_active Expired - Lifetime
- 1998-06-09 AT AT98929521T patent/ATE384528T1/de active
- 1998-06-09 CN CNB988081202A patent/CN1253150C/zh not_active Expired - Lifetime
- 1998-06-09 BR BR9810520-5A patent/BR9810520A/pt not_active Application Discontinuation
- 1998-06-10 DZ DZ980122A patent/DZ2512A1/xx active
- 1998-06-10 CO CO98033125A patent/CO4940476A1/es unknown
- 1998-06-12 HR HR980322A patent/HRP980322B1/xx not_active IP Right Cessation
- 1998-06-12 ZA ZA985137A patent/ZA985137B/xx unknown
- 1998-06-12 AR ARP980102794A patent/AR012247A1/es not_active Application Discontinuation
- 1998-06-12 TW TW087109401A patent/TW565442B/zh not_active IP Right Cessation
- 1998-06-12 UY UY25044A patent/UY25044A1/es not_active IP Right Cessation
- 1998-06-13 MY MYPI98002643A patent/MY124648A/en unknown
- 1998-09-15 SA SA98190552A patent/SA98190552B1/ar unknown
- 1998-10-29 GT GT199800171A patent/GT199800171A/es unknown
-
1999
- 1999-11-30 IS IS5280A patent/IS2619B/is unknown
- 1999-12-10 NO NO19996137A patent/NO323739B1/no not_active IP Right Cessation
-
2001
- 2001-05-16 HK HK01103404A patent/HK1032750A1/xx not_active IP Right Cessation
-
2003
- 2003-01-07 US US10/337,571 patent/US20040092477A1/en not_active Abandoned
-
2008
- 2008-03-31 CY CY20081100356T patent/CY1107912T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04737B1 (et) | Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega | |
NZ297118A (en) | Antithrombotic formulation; comprises thrombin inhibitor and one or more absorption enhancing agents | |
DE69836008D1 (de) | Zusammensetzung und behandlungsmittel | |
IS5574A (is) | Útskiptir Xa-þáttar oxóasaheterósýklýl-tálmar | |
FI971969A0 (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
NO961223D0 (no) | Öket korrosjonsbeskyttelse ved bruk av friksjonsreduksjonsmidler i forbindelse med korrosjonsinhibitorer | |
IS5341A (is) | Samsett meðferð sem inniheldur atórvastatin og þrýstingslækkandi miðil | |
DE69519672D1 (de) | Synergistische tensidzusammensetzungen und konzentrate davon zur feuerbekämpfung | |
DE69607321D1 (de) | Reinigungsverfahren und zusammensetzung | |
PL335166A1 (en) | Synergic combination of sulphonylurea and glytazone | |
ID24196A (id) | Komposisi dan penggunaan | |
EE9800339A (et) | Aminoisokinoliinid ja aminotienopüridiini derivaadid ning nende kasutamine põletikuvastaste ainetena | |
DE69725625D1 (de) | Reinigungs- und/oder desinfektionsmittel | |
DE69918842D1 (de) | Desinfektionszusammensetzungen und verfahren | |
DE69620642D1 (de) | Reiningungsverfahren und-zusammensetzung | |
BR9500630A (pt) | Composição absorvente sólida e artigo fabricado incluindo uma composição absorvente sólida | |
DE69919340D1 (de) | Überzugszusammensetzungen und verfahren | |
BR9510062A (pt) | Macromonômeto esterificado e composição | |
EP1053988A4 (en) | trimethylcyclohexane derivatives and melanin-forming inhibitors, and perfume-containing agents containing them | |
IL131085A0 (en) | The use of levobupivacaine or ropivacaine in treating migraine | |
DE69831059D1 (de) | Azeotropische oder azeotropähnliche zusammensetzungen und ihre verwendungen | |
NO20006626D0 (no) | Beleggingsmiddel og anvendelse herav | |
AU7688998A (en) | Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema | |
DE59711418D1 (de) | Pulverförmige Wasch- und Reinigungsmittel-Komponente | |
KR960004703U (ko) | 컵받침 겸 컨솔 도어 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB1A | Change in the ownership or in the address of the owner | ||
HC1A | Change of owner name | ||
HC1A | Change of owner name | ||
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |